Hanson & Doremus Investment Management historic quarter change: Foreign ADRs, Reduced
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Hanson & Doremus Investment Management opened 32 positions, added to 31, reduced 68 and sold out of 35.
- Q4 2025: Stock AstraZeneca plc ADR; Country of operation —; Class ADR; Shares before 12,832.
- Q3 2025: Stock AstraZeneca plc ADR; Country of operation —; Class ADR; Shares before 14,317.
- Q2 2025: Stock AstraZeneca plc ADR; Country of operation —; Class ADR; Shares before 14,351.
- Q1 2025: Stock AstraZeneca plc ADR; Country of operation —; Class ADR; Shares before 14,491.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1393944), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-29); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-17); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-20); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-15); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-17); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-17); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-01-23); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-17); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-08); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-22); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-29); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-12); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-11); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-12); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-31); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-11); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-06); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-10); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-12); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-30); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-30); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-17). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2007-06-30. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q4 2025 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 12,832 | 12,409 | -423 | $984 | $1,141 | +$157 | 2026-01-20 |
|---|
| Q3 2025 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 14,317 | 12,832 | -1,485 | $1,000 | $984 | -$16 | 2025-10-15 |
|---|
| Q2 2025 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 14,351 | 14,317 | -34 | $1,055 | $1,000 | -$55 | 2025-07-17 |
|---|
| Q1 2025 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 14,491 | 14,351 | -140 | $949 | $1,055 | +$106 | 2025-04-17 |
|---|
| Q4 2024 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 14,621 | 14,491 | -130 | $1,139 | $949 | -$190 | 2025-01-23 |
|---|
| Q3 2024 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 14,983 | 14,621 | -362 | $1,169 | $1,139 | -$30 | 2024-10-17 |
|---|
| Q1 2024 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 15,210 | 14,983 | -227 | $1,024 | $1,015 | -$9 | 2024-04-22 |
|---|
| Q3 2016 | Tata Motors Ltd ADR
CUSIP 876568502 | | ADR | 36,075 | 33,490 | -2,585 | $1,251,000 | $1,339,000 | +$88,000 | 2016-11-14 |
|---|
| Q3 2016 | America Movil L ADR
CUSIP 02364W105 | | ADR | 19,383 | 14,069 | -5,314 | $238,000 | $161,000 | -$77,000 | 2016-11-14 |
|---|
| Q3 2016 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 33,010 | 32,365 | -645 | $997,000 | $1,064,000 | +$67,000 | 2016-11-14 |
|---|
| Q3 2016 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 9,195 | 8,855 | -340 | $683,000 | $630,000 | -$53,000 | 2016-11-14 |
|---|
| Q3 2016 | Shire Plc ADR
CUSIP 82481R106 | | ADR | 2,371 | 2,140 | -231 | $436,000 | $415,000 | -$21,000 | 2016-11-14 |
|---|
| Q3 2016 | Glaxo Smithkline ADR
CUSIP 37733W105 | | ADR | 26,807 | 26,607 | -200 | $1,162,000 | $1,148,000 | -$14,000 | 2016-11-14 |
|---|
| Q3 2016 | Fibria Celulose S.A. ADR
CUSIP 31573A109 | | ADR | 1,009 | 336 | -673 | $7,000 | $2,000 | -$5,000 | 2016-11-14 |
|---|
| Q2 2016 | Tata Motors Ltd ADR
CUSIP 876568502 | | ADR | 36,120 | 36,075 | -45 | $1,049,000 | $1,251,000 | +$202,000 | 2016-07-29 |
|---|
| Q2 2016 | America Movil L ADR
CUSIP 02364W105 | | ADR | 20,838 | 19,383 | -1,455 | $324,000 | $238,000 | -$86,000 | 2016-07-29 |
|---|
| Q2 2016 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 33,660 | 33,010 | -650 | $948,000 | $997,000 | +$49,000 | 2016-07-29 |
|---|
| Q2 2016 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 9,350 | 9,195 | -155 | $668,000 | $683,000 | +$15,000 | 2016-07-29 |
|---|
| Q1 2016 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 34,040 | 33,660 | -380 | $1,156,000 | $948,000 | -$208,000 | 2016-05-12 |
|---|
| Q1 2016 | Glaxo Smithkline ADR
CUSIP 37733W105 | | ADR | 30,275 | 26,807 | -3,468 | $1,222,000 | $1,087,000 | -$135,000 | 2016-05-12 |
|---|
| Q1 2016 | Royal Dutch Shell ADR
CUSIP 780259206 | | ADR | 39,610 | 39,195 | -415 | $1,814,000 | $1,899,000 | +$85,000 | 2016-05-12 |
|---|
| Q1 2016 | Fibria Celulose S.A. ADR
CUSIP 31573A109 | | ADR | 2,760 | 1,009 | -1,751 | $35,000 | $9,000 | -$26,000 | 2016-05-12 |
|---|
| Q1 2016 | America Movil L sh ADR
CUSIP 02364W105 | | ADR | 21,694 | 20,838 | -856 | $305,000 | $324,000 | +$19,000 | 2016-05-12 |
|---|
| Q1 2016 | New Oriental Ed ADR
CUSIP 647581107 | | ADR | 1,115 | 590 | -525 | $35,000 | $20,000 | -$15,000 | 2016-05-12 |
|---|
| Q1 2016 | Total SA ADR
CUSIP 89151E109 | | ADR | 712 | 415 | -297 | $32,000 | $19,000 | -$13,000 | 2016-05-12 |
|---|
| Q1 2016 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 9,570 | 9,350 | -220 | $665,000 | $668,000 | +$3,000 | 2016-05-12 |
|---|
| Q4 2015 | Royal Dutch Shell ADR
CUSIP 780259206 | | ADR | 45,255 | 39,610 | -5,645 | $2,145,000 | $1,814,000 | -$331,000 | 2016-02-11 |
|---|
| Q4 2015 | Mindray Med Int'l ADR
CUSIP 602675100 | | ADR | 38,139 | 36,939 | -1,200 | $834,000 | $1,002,000 | +$168,000 | 2016-02-11 |
|---|
| Q4 2015 | America Movil L sh ADR
CUSIP 02364W105 | | ADR | 25,352 | 21,694 | -3,658 | $420,000 | $305,000 | -$115,000 | 2016-02-11 |
|---|
| Q4 2015 | Westpac Banking ADR
CUSIP 961214301 | | ADR | 6,500 | 6,375 | -125 | $137,000 | $154,000 | +$17,000 | 2016-02-11 |
|---|
| Q4 2015 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 9,660 | 9,570 | -90 | $673,000 | $665,000 | -$8,000 | 2016-02-11 |
|---|
| Q4 2015 | Fibria Celulose S.A. ADR
CUSIP 31573A109 | | ADR | 2,928 | 2,760 | -168 | $40,000 | $35,000 | -$5,000 | 2016-02-11 |
|---|
| Q3 2015 | Royal Dutch Shell ADR
CUSIP 780259206 | | ADR | 48,048 | 45,255 | -2,793 | $2,739,000 | $2,145,000 | -$594,000 | 2015-11-12 |
|---|
| Q3 2015 | Mindray Med Int'l ADR
CUSIP 602675100 | | ADR | 38,844 | 38,139 | -705 | $1,107,000 | $834,000 | -$273,000 | 2015-11-12 |
|---|
| Q3 2015 | America Movil L sh ADR
CUSIP 02364W105 | | ADR | 28,670 | 25,352 | -3,318 | $611,000 | $420,000 | -$191,000 | 2015-11-12 |
|---|
| Q3 2015 | Ensco Plc Adr
CUSIP 29358Q109 | | ADR | 9,540 | 7,310 | -2,230 | $212,000 | $103,000 | -$109,000 | 2015-11-12 |
|---|
| Q3 2015 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 10,105 | 9,660 | -445 | $652,000 | $673,000 | +$21,000 | 2015-11-12 |
|---|
| Q2 2015 | Vodafone Airtouch ADR
CUSIP 92857W209 | | ADR | 88,127 | 88,115 | -12 | $2,880,000 | $3,212,000 | +$332,000 | 2015-07-31 |
|---|
| Q2 2015 | Royal Dutch Shell ADR
CUSIP 780259206 | | ADR | 48,104 | 48,048 | -56 | $2,869,000 | $2,739,000 | -$130,000 | 2015-07-31 |
|---|
| Q2 2015 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 18,375 | 18,270 | -105 | $1,257,000 | $1,164,000 | -$93,000 | 2015-07-31 |
|---|
| Q2 2015 | GDF Suez Adr
CUSIP 36160B105 | | ADR | 24,031 | 20,733 | -3,298 | $476,000 | $386,000 | -$90,000 | 2015-07-31 |
|---|
| Q2 2015 | Ensco Plc Adr
CUSIP 29358Q109 | | ADR | 14,255 | 9,540 | -4,715 | $300,000 | $212,000 | -$88,000 | 2015-07-31 |
|---|
| Q2 2015 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 11,175 | 10,105 | -1,070 | $722,000 | $652,000 | -$70,000 | 2015-07-31 |
|---|
| Q2 2015 | Total SA ADR
CUSIP 89151E109 | | ADR | 1,375 | 700 | -675 | $68,000 | $34,000 | -$34,000 | 2015-07-31 |
|---|
| Q2 2015 | Fibria Celulose S.A. ADR
CUSIP 31573A109 | | ADR | 3,803 | 2,928 | -875 | $54,000 | $40,000 | -$14,000 | 2015-07-31 |
|---|
| Q2 2015 | America Movil L sh adr
CUSIP 02364W105 | | ADR | 29,542 | 28,670 | -872 | $604,000 | $611,000 | +$7,000 | 2015-07-31 |
|---|
| Q1 2015 | GDF Suez Adr
CUSIP 36160B105 | | ADR | 28,030 | 24,031 | -3,999 | $653,000 | $476,000 | -$177,000 | 2015-05-11 |
|---|
| Q1 2015 | Ensco Plc Adr
CUSIP 29358Q109 | | ADR | 15,065 | 14,255 | -810 | $451,000 | $300,000 | -$151,000 | 2015-05-11 |
|---|
| Q1 2015 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 11,245 | 11,175 | -70 | $795,000 | $722,000 | -$73,000 | 2015-05-11 |
|---|
| Q1 2015 | America Movil L sh adr
CUSIP 02364W105 | | ADR | 30,062 | 29,542 | -520 | $667,000 | $604,000 | -$63,000 | 2015-05-11 |
|---|
| Q1 2015 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 18,455 | 18,375 | -80 | $1,299,000 | $1,257,000 | -$42,000 | 2015-05-11 |
|---|
| Q1 2015 | Tata Motors Ltd ADR
CUSIP 876568502 | | ADR | 23,310 | 22,475 | -835 | $986,000 | $1,013,000 | +$27,000 | 2015-05-11 |
|---|
| Q1 2015 | Total SA ADR
CUSIP 89151E109 | | ADR | 1,480 | 1,375 | -105 | $76,000 | $68,000 | -$8,000 | 2015-05-11 |
|---|
| Q4 2014 | GDF Suez Adr
CUSIP 36160B105 | | ADR | 29,252 | 28,030 | -1,222 | $733,000 | $653,000 | -$80,000 | 2015-02-06 |
|---|
| Q4 2014 | Tata Motors Ltd ADR
CUSIP 876568502 | | ADR | 23,450 | 23,310 | -140 | $1,025,000 | $986,000 | -$39,000 | 2015-02-06 |
|---|
| Q4 2014 | National Grid Plc ADR
CUSIP 636274300 | | ADR | 11,470 | 11,245 | -225 | $824,000 | $795,000 | -$29,000 | 2015-02-06 |
|---|
| Q4 2014 | Cheung Kong Hldg ADR
CUSIP 166744201 | | ADR | 1,625 | 625 | -1,000 | $27,000 | $10,000 | -$17,000 | 2015-02-06 |
|---|
| Q3 2014 | GDF Suez Adr
CUSIP 36160B105 | | ADR | 30,034 | 29,252 | -782 | $831,000 | $733,000 | -$98,000 | 2014-11-10 |
|---|
| Q3 2014 | Tata Motors Ltd ADR
CUSIP 876568502 | | ADR | 24,520 | 23,450 | -1,070 | $958,000 | $1,025,000 | +$67,000 | 2014-11-10 |
|---|
| Q3 2014 | AstraZeneca plc ADR
CUSIP 046353108 | | ADR | 18,555 | 18,455 | -100 | $1,379,000 | $1,318,000 | -$61,000 | 2014-11-10 |
|---|
| Q2 2014 | Royal Dutch Shell ADR
CUSIP 780259206 | | ADR | 46,884 | 44,829 | -2,055 | $3,425,000 | $3,693,000 | +$268,000 | 2014-08-12 |
|---|
| Q2 2014 | Tata Motors Ltd ADR
CUSIP 876568502 | | ADR | 33,440 | 24,520 | -8,920 | $1,184,000 | $958,000 | -$226,000 | 2014-08-12 |
|---|
| Q2 2014 | Glaxo Smithkline ADR
CUSIP 37733W105 | | ADR | 26,981 | 23,331 | -3,650 | $1,442,000 | $1,248,000 | -$194,000 | 2014-08-12 |
|---|
| Q2 2014 | Fibria Celulose S.A. ADR
CUSIP 31573A109 | | ADR | 5,385 | 3,803 | -1,582 | $60,000 | $37,000 | -$23,000 | 2014-08-12 |
|---|
| Q2 2014 | America Movil L sh adr
CUSIP 02364W105 | | ADR | 29,722 | 29,128 | -594 | $591,000 | $604,000 | +$13,000 | 2014-08-12 |
|---|
| Q2 2014 | GDF Suez Adr
CUSIP 36160B105 | | ADR | 30,329 | 30,034 | -295 | $829,000 | $831,000 | +$2,000 | 2014-08-12 |
|---|
| Q3 2013 | Mindray Med Int'l ADR
CUSIP 602675100 | | ADR | 31,764 | 31,174 | -590 | $1,190,000 | $1,212,000 | +$22,000 | 2013-10-17 |
|---|
| Q3 2013 | Glaxo Smithkline ADR
CUSIP 37733W105 | | ADR | 27,796 | 27,631 | -165 | $1,389,000 | $1,386,000 | -$3,000 | 2013-10-17 |
|---|